Inhibition of chemiluminescence by carvedilol in the cell‐free system, whole human blood and blood cells
Authors:
- 1 February 2005
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 65 (1) , 55-64
Abstract
Carvedilol inhibits luminol‐enhanced chemiluminescence of reactive oxygen metabolites in vitro. In this study it was found that, in the cell‐free system, carvedilol dose‐dependently decreased chemiluminescence in the following ranking order of radicals: hydroxyl radical>hydrogen peroxide>superoxide radical. The inhibition of myeloperoxidase was significant with carvedilol concentrations of 10 and 100 µmol/l and manifested in the concentration‐dependent shift of chemiluminescence peaks to the right. In whole blood, carvedilol in concentrations of 10 and 100 µmol/l significantly inhibited chemiluminescence induced by both receptor‐bypassing stimuli (A23187, PMA) and receptor‐operating stimuli (fMLP, OpZ). Carvedilol dose‐dependently inhibited chemiluminescence of isolated human polymorphonuclear leucocytes in the ranking order of stimuli: A23187>OpZ>fMLP. In the presence of blood platelets, carvedilol did not substantially change chemiluminescence induced by fMLP and OpZ, while it was much more effective on chemiluminescence stimulated with calcium ionophore A23187. This could be the result of the supportive effect of serotonin liberated from platelets by A23187.Keywords
This publication has 10 references indexed in Scilit:
- Oxidative killing of microbes by neutrophilsMicrobes and Infection, 2003
- Cationic amphiphilic drugs and platelet phospholipase A2 (cPLA2)Thrombosis Research, 2002
- Redox properties of the couple compound I/native enzyme of myeloperoxidase and eosinophil peroxidaseEuropean Journal of Biochemistry, 2001
- Mechanism of reaction of myeloperoxidase with hydrogen peroxide and chloride ionEuropean Journal of Biochemistry, 2000
- Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion modelEuropean Journal of Pharmacology, 1998
- One- and Two-Electron Oxidations of Luminol by Peroxidase SystemsFree Radical Biology and Medicine, 1998
- Essential Requirement of Cytosolic Phospholipase A2for Activation of the Phagocyte NADPH OxidaseJournal of Biological Chemistry, 1998
- Carvedilol, a new vasodilating adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophilsCardiovascular Research, 1994
- Luminol chemiluminescence and active oxygen generation by activated neutrophilsArchives of Biochemistry and Biophysics, 1991
- Liquid Chromatographic Assay and Disposition of Carvedilol in Healthy VolunteersJournal of Pharmaceutical Sciences, 1986